https://www.thebody.com/health/hiv-viread-tenofovir-tdf
HIV MedicationsViread

Viread (Tenofovir Disoproxil Fumarate) for HIV Treatment & PrEP: Everything You Need to Know

illustration of larger-than-life Viread bottle alongside a person holding a massive Viread pill
Lily Fulop

    Frequently Asked QuestionsViread

    What is Viread used for?

    Viread is a medication in the class of drugs called “nucleoside / nucleotide reverse transcriptase inhibitors” (NRTIs), which stop HIV from making copies of itself early in the viral life cycle. Viread is used for the treatment and prevention of HIV in combination with other drugs. Viread is also used to treat chronic hepatitis B. Viread was approved by the U.S. Food and Drug Administration (FDA) in United States in 2001, and became available as a generic medication in 2017.

    How often is Viread taken?

    Viread is normally taken orally once a day as a 300 mg pill, ideally with a meal (but it’s not required). The most important thing is to try to take it at the same time every day. Some adults who have issues with their kidneys may be instructed to take Viread less frequently. Always follow your medical provider’s instructions for how and when to take Viread.

    Does Viread have any side effects I should worry about?

    Viread is usually very well tolerated. The most common side effects of Viread are headache, nausea, and diarrhea. Tell your medical provider if you develop any side effects.

    What anti-HIV pills contain Viread?

    Viread is a part of seven different fixed-dose combination pills used to fight HIV (fixed-dose combinations contain multiple HIV drugs in one pill): Atripla, Cimduo, Complera, Delstrigo, Stribild, Symfi Lo, and Truvada. Truvada is used not only for HIV treatment, for also for HIV prevention as a pre-exposure prophylaxis (PrEP) regimen.

    Michael Broder

    Michael Broder

    Michael H. Broder is a same-sex-married, HIV-positive man of learning and letters living in Bed-Stuy, Brooklyn. He holds a PhD in classics from CUNY and an MFA in creative writing from NYU. His book of poems, This Life Now (A Midsummer Night's Press, 2014), was a finalist for a Lambda Literary Award. He is the publisher of Indolent Books, a small nonprofit poetry press, and founder of the HIV Here & Now poetry project.